Section Arrow
Quote
BVS.NASDAQ
- Bioventus
Quotes are at least 15-min delayed:2025/04/29 13:12 EDT
Last
 7.445
+0.015 (+0.20%)
Day High 
7.505 
Prev. Close
7.43 
1-M High
9.56 
Volume 
139.38K 
Bid
7.44
Ask
7.45
Day Low
7.345 
Open
7.41 
1-M Low
7.13 
Market Cap 
492.09M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.67 
20-SMA 8.05 
50-SMA 9.11 
52-W High 14.38 
52-W Low 3.9518 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.52/0.99
Enterprise Value
800.38M
Balance Sheet
Book Value Per Share
2.23
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
573.28M
Operating Revenue Per Share
7.59
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.61+0.43+0.42%82.3PE
PACBPacific Biosciences of California1.12-0.01-0.88%-- 
SENSSenseonics Holdings0.7435+0.0219+3.03%-- 
EWEdwards Lifesciences Corp75.85+0.31+0.41%32.28PE
MDTMedtronic plc84.58+0.54+0.64%25.62PE
Quotes are at least 15-min delayed：2025/04/29 13:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.